ORIFARM PI A/S: Financial statements 2014
CVR: 27347177
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ORIFARM PI A/S (CVR 27347177) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -30,000 and a net result of DKK 18,740,000 compared with DKK 18,511,000 the year before. Equity in the 2014 report amounted to DKK 58,990,000. The solvency ratio was 39.2%.
- Gross Profit
- DKK -30,000
- Profit/Loss
- DKK 18,740,000
- Equity
- DKK 58,990,000
- Total Assets
- DKK 150,377,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -30K | 18.7M | 59M | - |
| 2013 | - | -30K | 18.5M | 42.6M | - |
| 2012 | - | -46K | 17.6M | 25.6M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ORIFARM PI A/S has published its annual report for 2013. Gross profit came to DKK -30,000, and the net result was DKK 18,511,000.
As of May 13, 2014, Birgitte Bøgh-Sørensen has joined the board of directors of ORIFARM PI A/S.
As of May 13, 2014, Erik Sandberg is registered as adm. dir. of ORIFARM PI A/S.
As of May 13, 2014, Hans Carl Bøgh-Sørensen has stepped down as adm. dir. of ORIFARM PI A/S.
On May 13, 2014, the company changed its name from ORIFARM HOLDING A/S to ORIFARM PI A/S.
About ORIFARM PI A/S
ORIFARM PI A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Finansielle holdingselskaber. The company was previously named ORIFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -446,000 and a net result of DKK 298,665,000 compared with DKK 320,939,000 the year before. Equity in the 2025 report amounted to DKK 1,391,995,000.